Abstract
Aims: This study investigates the hypoglycemic potential of Archachatina marginata haemolymph and its mechanism in streptozotocin -induced diabetic rats. Study Design: One factor experimental design. Place and Duration of Study: Department of Chemical Sciences, Joseph Ayo Babalola University, Ikeji Arakeji, Osun State, Nigeria between January to June, 2015. Methodology: The rats were set into four groups (n=5). Group 1 - Non-diabetic control (NDC), Group 2 - Diabetic Control (DC), Group 3 - Diabetic rats with 1 mL administration of snail Original Research Article Adeboye et al.; JPRI, 18(1): 1-8, 2017; Article no.JPRI.33786 2 haemolymph (DSS1), Group 4 - Diabetic rats with 2 mL snail haemolymph administration (DSS2). The blood glucose concentration of each rat was taken and thereafter, they were weighed and then administered with 55 mg/kg STZ in citrate buffer (pH 4.5) peritoneally non-diabetic control group (NDC). Rats with blood glucose level of 200 mg/dL and above were considered diabetic. Haemolymph of 1 mL and 2 mL were administered to rats in DSS1 and DSS2 respectively while DC received 2 mL distilled water for 14 consecutive days. Physiological orangs and blood samples were harvested for various analysis. Results: The A. marginata haemolymph significantly improved the plasma concentration of insulin and reduced plasma glucose level in a dose dependent manner P=.05. Conclusion: The A. marginata haemolymph has potential to exact hypoglycemic effect and improve the insulin concentration in streptozotocin induced diabetic rat. Keywords: Archachatina marginata; haemolymph; streptozocin diabetes rats.
Highlights
Diabetes mellitus (DM) is a metabolic disease characterized by persistent hyperglycemia resulting from insulin deficiency or insulin resistance or both
This study investigates the hypoglycemic potential of Archachatina marginata haemolymph and its mechanism in streptozotocin -induced diabetic rats
In continuation to source for a safe therapeutic agent in treating diabetes, this study investigates the hypoglycemic potential of A. marginata haemolymph and its mechanism in streptozotocin -induced diabetic rats
Summary
Diabetes mellitus (DM) is a metabolic disease characterized by persistent hyperglycemia resulting from insulin deficiency or insulin resistance or both. Orthodox sources have continued to be valuable therapeutic agents especially in treating non communicable diseases such as snail’s hemolymph which is used in folk medicine [4,5]. It is believed that various preparations containing snails are useful in restoring fertility, virility and to cure smallpox [8]. It is used as relieve in labour pains, blood loss in pregnancy and during delivery. In continuation to source for a safe therapeutic agent in treating diabetes, this study investigates the hypoglycemic potential of A. marginata haemolymph and its mechanism in streptozotocin -induced diabetic rats
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
